Everence Capital Management Inc Catalent, Inc. Transaction History

Everence Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 04, 2023	BUY	$45.44 - $74.26 $239,014 - $390,607	5,260 New	5,260 $346,000
Q1 2022 Apr 11, 2022	SELL	$94.19 - $124.49 $159,181 - $210,388	-1,690 Reduced 22.06%	5,970 $662,000
Q4 2021 Jan 28, 2022	BUY	$119.57 - $139.07 $559,587 - $650,847	4,680 Added 157.05%	7,660 $981,000
Q4 2020 Feb 01, 2021	BUY	$85.88 - $105.36 $255,922 - $313,972	2,980 New	2,980 $310,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Everence Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Everence Capital Management Inc with notifications on news.